Logo image of EMR

EMERSON ELECTRIC CO (EMR) Stock Analyst Earnings Estimates

NYSE:EMR - New York Stock Exchange, Inc. - US2910111044 - Common Stock - Currency: USD

121.85  -2.9 (-2.32%)

After market: 121.85 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
EMR revenue by date.EMR revenue by date.
19.629B
7.64%
15.165B
-22.74%
17.492B
15.34%
18.318B
4.72%
19.238B
5.02%
20.194B
4.97%
21.796B
7.93%
23.515B
7.89%
24.926B
6.00%
EBITDA
YoY % growth
EMR ebitda by date.EMR ebitda by date.
4.686B
11.97%
3.955B
-15.60%
4.148B
4.88%
5.097B
22.88%
5.447B
6.87%
5.865B
7.67%
6.134B
4.59%
6.106B
-0.46%
N/A
EBIT
YoY % growth
EMR ebit by date.EMR ebit by date.
3.647B
13.40%
2.904B
-20.37%
2.459B
-15.32%
4.39B
78.53%
4.747B
8.13%
4.907B
3.37%
5.452B
11.11%
N/AN/A
Operating Margin
EMR operating margin by date.EMR operating margin by date.
18.58%19.15%14.06%23.97%24.68%24.30%25.01%N/AN/A
EPS
YoY % growth
EMR eps by date.EMR eps by date.
5.25
28.05%
4.41
-16.00%
5.49
24.49%
6.02
9.67%
6.50
7.93%
7.17
10.28%
7.76
8.24%
8.03
3.52%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
1.42
4.38%
1.55
8.53%
1.64
11.00%
1.50
8.91%
1.60
12.75%
1.70
9.79%
1.78
8.51%
1.56
3.62%
1.76
10.18%
1.88
10.60%
1.93
8.22%
Revenue
Q2Q % growth
4.423B
1.07%
4.591B
4.82%
4.85B
5.00%
4.415B
5.75%
4.782B
8.12%
4.891B
6.53%
5.149B
6.16%
4.667B
5.71%
5.02B
4.98%
5.174B
5.79%
5.399B
4.86%
EBITDA
Q2Q % growth
1.213B
-23.95%
1.312B
-28.03%
1.325B
-46.01%
1.254B
5.11%
1.349B
11.21%
1.439B
9.68%
1.46B
10.19%
1.296B
3.35%
1.454B
7.78%
1.563B
8.62%
1.583B
8.42%
EBIT
Q2Q % growth
1.058B
41.26%
1.15B
105.36%
1.206B
57.65%
1.059B
30.74%
1.264B
19.47%
1.335B
16.09%
1.356B
12.44%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
1.38
13.11%
1.290.096.76%
Q4 2024
Q2Q % growth
1.48
14.73%
1.480.00-0.15%
Q3 2024
Q2Q % growth
1.43
10.85%
1.430.00-0.19%
Q2 2024
Q2Q % growth
1.36
29.52%
1.270.097.48%
Q1 2024
Q2Q % growth
1.22
56.41%
1.050.1715.96%
Q4 2023
Q2Q % growth
1.29
-15.69%
1.32-0.03-2.44%
Q3 2023
Q2Q % growth
1.29
-6.52%
1.110.1815.93%
Q2 2023
Q2Q % growth
1.05
-18.60%
0.980.076.80%
Q1 2023
Q2Q % growth
0.78
-25.71%
0.88-0.10-11.60%
Q4 2022
Q2Q % growth
1.53
26.45%
1.400.139.56%
Q3 2022
Q2Q % growth
1.38
26.61%
1.310.075.26%
Q2 2022
Q2Q % growth
1.29
32.99%
1.190.108.16%
Q1 2022
Q2Q % growth
1.05
26.51%
1.000.054.70%
Q4 2021
Q2Q % growth
1.21
10.00%
1.190.021.30%
Q3 2021
Q2Q % growth
1.09
36.25%
0.990.1010.02%
Q2 2021
Q2Q % growth
0.97
8.99%
0.910.067.04%
Q1 2021
Q2Q % growth
0.83
23.88%
0.690.1420.67%
Q4 2020
Q2Q % growth
1.10
-5.17%
0.950.1515.27%
Q3 2020
Q2Q % growth
0.80
-14.89%
0.600.2032.70%
Q2 2020
Q2Q % growth
0.89
5.95%
0.750.1419.35%
Q1 2020
Q2Q % growth
0.67
-9.46%
0.68-0.01-1.17%
Q4 2019
Q2Q % growth
1.16 1.090.076.43%
Q3 2019
Q2Q % growth
0.94 0.95-0.01-1.14%
Q2 2019
Q2Q % growth
0.84 0.85-0.01-1.06%
Q1 2019
Q2Q % growth
0.74 0.670.0710.98%
EMR Yearly EPS VS EstimatesEMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
4.175B
1.41%
4.274B-99M-2.32%
Q4 2024
Q2Q % growth
4.619B
12.93%
4.611B8M0.17%
Q3 2024
Q2Q % growth
4.38B
11.00%
4.494B-114M-2.54%
Q2 2024
Q2Q % growth
4.376B
16.51%
4.333B43M0.99%
Q1 2024
Q2Q % growth
4.117B
22.06%
3.958B159M4.02%
Q4 2023
Q2Q % growth
4.09B
-23.69%
4.236B-146M-3.45%
Q3 2023
Q2Q % growth
3.946B
-21.16%
3.914B32M0.82%
Q2 2023
Q2Q % growth
3.756B
-21.60%
3.684B72M1.95%
Q1 2023
Q2Q % growth
3.373B
6.88%
3.464B-91M-2.63%
Q4 2022
Q2Q % growth
5.36B
8.35%
5.37B-10M-0.19%
Q3 2022
Q2Q % growth
5.005B
6.56%
5.176B-171M-3.30%
Q2 2022
Q2Q % growth
4.791B
8.12%
4.758B33M0.69%
Q1 2022
Q2Q % growth
3.156B
-24.15%
4.518B-1.362B-30.15%
Q4 2021
Q2Q % growth
4.947B
8.53%
5.141B-194M-3.77%
Q3 2021
Q2Q % growth
4.697B
20.01%
4.641B56M1.21%
Q2 2021
Q2Q % growth
4.431B
6.44%
4.406B25M0.57%
Q1 2021
Q2Q % growth
4.161B
0.19%
4.016B145M3.61%
Q4 2020
Q2Q % growth
4.558B
-8.31%
4.504B54M1.20%
Q3 2020
Q2Q % growth
3.914B
-16.44%
3.887B27M0.69%
Q2 2020
Q2Q % growth
4.163B
-8.91%
4.322B-159M-3.68%
Q1 2020
Q2Q % growth
4.153B
0.14%
4.19B-37M-0.88%
Q4 2019
Q2Q % growth
4.971B 5.087B-116M-2.28%
Q3 2019
Q2Q % growth
4.684B 4.87B-186M-3.82%
Q2 2019
Q2Q % growth
4.57B 4.69B-120M-2.56%
Q1 2019
Q2Q % growth
4.147B 4.264B-117M-2.74%
EMR Yearly Revenue VS EstimatesEMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-4.17% -7.76% -0.14% 0.06%
Revenue-3.36% -4.41% -0.79% -0.98%